Abstract
Among the native squill glycosides, only proscillaridin A has so far found considerable clinical application. In addition, the semisynthetic meproscillarin (4’-methylproscillaridin A) was recently introduced. Pharmacokinetic knowledge of these glycosides has been obtained by indirect techniques based on clinical parameters and by measurements in plasma and other body fluids by use of 86Rb uptake inhibition assay or by 3 H-labeled glycosides. Generally, there is agreement between the results from the two approaches.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson, K.-E., Bertler, A., Redfors, A.: On the pharmacokinetics of proscillaridin A in man. Eur. J. Clin. Pharmacol. 8, 421–425 (1975)
Andersson, K.-E., Bergdahl, B., Bertler, A., Redfors, A.: On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects. Acta Pharmacol. Toxicol. (Kbh.) 40, 153–160 (1977a)
Andersson, K.-E., Bergdahl, B., Dencker, H., Wettrell, G.: Proscillaridin activity in portal and peripheral venous blood after oral administration to man. Eur. J. Clin. Pharmacol. 11, 277–281 (1977b)
Andersson, K.-E., Bergdahl, B., Dencker, H., Wettrell, G.: Activities of proscillaridin A in thoracic duct lymph after single oral doses in man. Acta Pharmacol. Toxicol. (Kbh.) 40, 280–284 (1977c)
Andersson, K.-E., Bergdahl, B., Wettrell, G.: Biliary excretion and enterohepatic recycling of proscillaridin A after oral administration to man. Eur. J. Clin. Pharmacol. 11, 273–276 (1977d)
Beckmann, H., Belz, G.G., Quellhorst, E.: Die Eliminationsgeschwindigkeit von Meproscillarin nach wiederholter Applikation bei Patienten mit eingeschränkter Nierenfunktion. Arzneim. Forsch. 28/1, 565–567 (1978)
Belz, G.G.: Klinisch-experimentelle Untersuchungen mit dem Herzglydosid Proscillaridin unter besonderer Berücksichtigung seiner enteralen Resorptionsquote. Med. Klin. 63, 96–102 (1968)
Betz, G.G., Bader, H.: Effect of oral charcoal on plasma levels of intravenous methylproscillaridin. Klin. Wochenschr. 52, 1134–1135 (1974)
Belz, G.G., Brech, W.J.: Plasmaspiegel und Kumulationsverhalten von Proscillaridin bei Niereninsuffizienz. Klin. Wochenschr. 52, 640–644 (1974)
Belz, G.G., Heinz, N.: The influence of polar and non-polar digoxin and digitoxin metabolites on the 86Rb-uptake of human erythrocytes and the contractility of guinea pig papillary muscles. Arzneim. Forsch. 27, 653–655 (1977)
Belz, G.G., Schreiter, H.: Influence of plasma on the glycoside induced inhibition of 66Rbuptake of human erythrocytes. Z. Kardiol. 63, 475–479 (1974)
Belz, G.G., Stauch, M., Belz, G., Kurbjuweit, H.G., Oberdorf, A.: The effect of various cardenolides and bufadienolides with different cardiac activity on the 86rubidium uptake of human erythrocytes. Naunyn-Schmiedebergs Arch. Pharmacol. 280, 353–362 (1973)
Belz, G.G., Nübling, H., Schmidt-Wiederkehr, P., Franz, H.E.: Plasmakonzentrationen und Elimination von Methylproscillaridin bei Niereninsuffizienz. Klin. Wochenschr. 52, 1078–1081 (1974a)
Belz, G.G., Rudofsky, G., Lossnitzer, K., Wolf, G., Stauch, M.: Plasmaspiegel und Elektrokardiogramm nach intravenöser Applikation von Proscillaridin und Digoxin. Z. Kardiol. 63, 201–211 (1974b)
Belz, G.G., Stauch, M., Rudofsky, G.: Plasma levels after a single oral dose of proscillaridin. Eur. J. Clin. Pharmacol. 7, 95–97 (1974c)
Belz, G.G., Schreiter, H., Wolf, G.K.: Pharmacokinetics and pharmacodynamics of methylproscillaridin in healthy man. Eur. J. Clin. Pharmacol. 10, 101–108 (1976)
Bergdahl, B.: An account of proscillaridin with special reference to its pharmacokinetics. Linköping University Medical Dissertations No. 50, Linköping 1977
Bergdahl, B.: Disposition rate of proscillaridin A in man after multiple oral doses. Arzneim. Forsch. 29/1, 343–345 (1979)
Bergdahl, B., Andersson, K.-E.: Stability in vitro of methylproscillaridin. Eur. J. Clin. Pharmacol. 11, 267–271 (1977)
Bulitta, A.: Resorptions-, Abklingquote und klinische Wirksamkeit von Talusin. Med. Welt 25,1374–1377(1974)
Hänel, J., Meiffert, G.: Klinisch-experimentelle Studie zur Charakterisierung eines Herzglykosids. Med. Welt 19, 1404–1408 (1966)
Herken, H., Brandes, J.: Klinische Prüfung von Meproscillarin im Hinblick auf Abklingund Persistenzquote, Bioverfügbarkeit und Erhaltungsdosis. Arzneim. Forsch. 28/1, 557–560 (1978)
Löschhorn, N.: Probleme der quantitativen Prüfung von Herzglykosiden, dargestellt an Proscillaridin. Therapiewoche 19, 1529–1532 (1969)
Meier, G., Wagner, G.: Therapeutische Erfahrungen mit einem neuen Herzglykosid: Proscillaridin A. Med. Welt 18, 1995–2002 (1965)
Rietbrock, N., Staud, R.: Metabolism and excretion of methylproscillaridin by man. Eur. J. Clin. Pharmacol. 8, 427–432 (1975)
Staud, R., Rietbrock, N., Fassbender, H.P.: Excretion of methylproscillaridin in patients with a biliary fistula. Eur. J. Clin. Pharmacol. 9, 99–103 (1975)
Twittenhoff, W.-D., Brittinger, W.D., Deckert, D.W., Belz, G.G., Schubert, I.: Zur Frage der Kumulation von Meproscillarin bei Niereninsuffizienz. Arzneim. Forsch. 28/1, 562–565 (1978)
Weymann, J., Schenk, G., Kesselring, K.: Untersuchungen zur Disposition von Meproscillarin an den Spezies Ratte und Hund. Arzneim. Forsch. 28/1, 520–526 (1978)
Wülfing von der Heyden, D.: Beitrag zur quantitativen und qualitativen Prüfung des Reinglykosids Proscillaridin. Med. Welt 22, 738–743 (1969)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andersson, KE., Bergdahl, B. (1981). Pharmacokinetics of Squill Glycosides. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68166-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-68166-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68168-4
Online ISBN: 978-3-642-68166-0
eBook Packages: Springer Book Archive